Syndax Pharmaceuticals Inc Stock, NASDAQ:SNDX
35 Gatehouse Drive, Building D, Waltham, Massachusetts 02451
United States of America
Number of Employees: 43
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.